<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="EUR" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://iatistandard.org/203/schema/downloads/iati-activities-schema.xsd">
  <iati-identifier>NL-KVK-41207989-P-11116-2013034 - 2S4KN</iati-identifier>
  <reporting-org ref="NL-KVK-41207989" type="21">
   <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Research on HIV latency in the viral reservoir</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Dr. Monique Nijhuis aims to characterize the latently HIV-infected viral reservoir in patients: How big is it, what is its composition and does the reservoir change during long-term antiretroviral therapy? Nijhuis also aims to determine the re-activation level required for the immune system to be able to recognise and eradicate these HIV-infected cells.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="EN">Many people live with HIV, but there is currently no cure. Presence of a stable reservoir of HIV-infected cells prevents eradication with contemporary treatment strategies. Targeting and eliminating these cells is essential for eradication, yet many basic questions about the composition of the latent reservoir remain unanswered.</narrative>
  </description>
  <description type="2">
   <narrative xml:lang="EN">This project aims to analyse size, characteristics and re-activation potential of the latently infected T-cell subsets and to obtain quantitative insights in the longevity of these subsets in vivo.
Highly-sensitive, digital-PCR technology will be combined with deep-sequence analysis to investigate size, composition and evolution of the viral reservoir in longitudinal plasma, PBMC and T-cell subsets in the same patients over 15 years of effective therapy. Characteristics of the PBMC and T-cell subsets will also be analyzed and related to their average in vivo life-span (D2O labeling) and their in vitro reactivation potential in a novel latency model. 
Aim 1) Identify and quantify the HIV reservoir in T-cell subsets over 15 years of effective cART.
Aim 2) Determine the characteristics of the different T-cell subsets with respect to longevity, immunological markers and viral quasispecies over time. 
Aim 3) Determine the reactivation potential of the latently infected T-cell subsets over time. 
Output: scientific publications

This study uses unique patient material and highly innovative techniques, never before employed in parallel, to characterize the HIV reservoir, opening a door to HIV eradication.</narrative>
  </description>
  <description type="3">
   <narrative xml:lang="EN">scientific community</narrative>
  </description>
  <participating-org ref="NL-KVK-41207989" role="1" type="22">
   <narrative xml:lang="EN">Aidsfonds Grants</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-41207989" role="2" type="22">
   <narrative xml:lang="EN">Aidsfonds</narrative>
  </participating-org>
  <participating-org ref="NL-KVK-30244197" role="4" type="80">
   <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2014-02-16" type="1"></activity-date>
  <activity-date iso-date="2018-08-15" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Aidsfonds - Soaaids Nederland</narrative>
   </organisation>
   <telephone>+31(0)206262669</telephone>
   <email>IATI@aidsfonds.nl</email>
  </contact-info>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Research on HIV latency in the viral reservoir STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="9" significance="1" vocabulary="1"></policy-marker>
  <collaboration-type code="3"></collaboration-type>
  <default-flow-type code="30"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="1" type="1">
   <period-start iso-date="2014-02-16"></period-start>
   <period-end iso-date="2018-08-15"></period-end>
   <value currency="EUR" value-date="2014-02-16">248115</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">105000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2013034, Aidsfonds Nijhuis</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-12-30"></transaction-date>
   <value currency="EUR" value-date="2015-12-30">105000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2013034, Aidsfonds Nijhuis</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-02-27"></transaction-date>
   <value currency="EUR" value-date="2016-02-27">15000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2013034, Aidsfonds Nijhuis</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-02-27"></transaction-date>
   <value currency="EUR" value-date="2016-02-27">15000</value>
   <description>
    <narrative xml:lang="EN">1490 DOSS 2013034, Aidsfonds Nijhuis</narrative>
   </description>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-06-26"></transaction-date>
   <value currency="EUR" value-date="2016-06-26">15000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-06-27"></transaction-date>
   <value currency="EUR" value-date="2016-06-27">15000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-10-27"></transaction-date>
   <value currency="EUR" value-date="2016-10-27">15000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-10-27"></transaction-date>
   <value currency="EUR" value-date="2016-10-27">15000</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-02-27"></transaction-date>
   <value currency="EUR" value-date="2017-02-27">14500</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-02-27"></transaction-date>
   <value currency="EUR" value-date="2017-02-27">14500</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-06-26"></transaction-date>
   <value currency="EUR" value-date="2017-06-26">14500</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-06-27"></transaction-date>
   <value currency="EUR" value-date="2017-06-27">14500</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-10-27"></transaction-date>
   <value currency="EUR" value-date="2017-10-27">14500</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-10-27"></transaction-date>
   <value currency="EUR" value-date="2017-10-27">14500</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-02-21"></transaction-date>
   <value currency="EUR" value-date="2019-02-21">54615</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-02-21"></transaction-date>
   <value currency="EUR" value-date="2019-02-21">54615</value>
   <provider-org ref="NL-KVK-41207989">
    <narrative xml:lang="EN">Aidsfonds Grants</narrative>
   </provider-org>
   <receiver-org ref="NL-KVK-30244197">
    <narrative xml:lang="EN">UMCU - Medical Microbiology, Virology</narrative>
   </receiver-org>
  </transaction>
 </iati-activity>
</iati-activities>
